Pharmaceutical Evaluation and Policy
M.S. in Pharmaceutical Evaluation and Policy

The Pharmaceutical Sciences M.S. program offers a curriculum with a concentration in Pharmaceutical Evaluation and Policy (PEP) to meet the training needs of persons with business, science, and health care backgrounds wishing to acquire the research skills in pharmaceutical evaluation and pharmacoeconomics, health outcomes assessment, policy analyses, and social behavioral research in pharmacy.  

Pharmaceuticals are increasingly being used to cure, treat, manage, or provide relief for many human afflictions, however, issues of financing, efficiency, access, adherence, and safety of pharmaceuticals continue to challenge the health care systems of the world.  The goal of the Pharmaceutical Evaluation and Policy (PEP) graduate program is to advance and disseminate knowledge about the delivery and value of pharmaceutical products and services and contribute to health policy and program development that benefits society.  Using a multidisciplinary approach, individuals in the program will acquire the abilities to conduct research that evaluates the value of pharmaceutical products, services, and financing systems.  The program will prepare individuals for managerial positions in the pharmaceutical industry, contract research organizations, managed care organizations, government agencies, academia, and will serve as a feeder program for graduates wishing to pursue PhD training.  Ultimately, a new UAMS PhD program will be developed in Pharmaceutical Evaluation and Policy for which graduates of the MS program could pursue.